Bright Future Pharmaceuticals Factory:

Please note that on February 28, 2022, CFDI sent the Notification of Drug Remote Inspection Results of  Glucosamine Hydrochloride Capsules to the agency of the medicine in China.

If there are any questions, please do not hesitate to contact us as soon as possible.

Contact: Kuang Yanwei

Tel. +86 10 68441668

  Center for Food and Drug Inspection of NMPA

February 28, 2022